TY - JOUR
T1 - The natural history of coccidioidal meningitis
T2 - Va—armed forces cooperative studies, 1955–1958
AU - Galgiani, John N.
AU - Vincent, Tom
AU - Huppert, Milton
AU - Salkin, David
N1 - Funding Information:
Received 22 June 1992; revised 15 September 1992. Financial support: This work was supported in part by the Office of Veterans Affairs and Pfizer Pharmaceuticals. * Deceased. Reprints or correspondence: Dr. John N. Galgiani, Medical Service (111), VA Medical Center, Tucson, Arizona 85723.
PY - 1993/2
Y1 - 1993/2
N2 - From records on the clinical course of 699 military and veteran patients who had coccidioidomycosis before the advent of effective antifungal therapy, we identified 25 cases in which the manifestations of meningeal dissemination were described. Of 21 patients who had an identifiable initial infection, 16 developed meningeal symptoms (most frequently headache, vomiting, and nuchal rigidity) within the next 6 months. Associated pulmonary lesions were significantly more frequent in the right than in the left lung, as was also the case among 47 matched control patients who had coccidioidomycosis but not meningitis. Of 17 patients whose meningeal symptoms developed during the period studied, all died within 31 months. However, four of eight patients whose onset of symptoms preceded the study period survived for 55–146 months. Patients whose extrapulmonary dissemination involved only the meninges survived significantly longer than did those with more extensive infections. Even without therapy, the white blood cell count in cerebrospinal fluid markedly decreased during the course of the infection. The quantitative analysis provided herein offers a basis for meaningful comparisons with patients enrolled in current and future trials of therapy for coccidioidal meningitis.
AB - From records on the clinical course of 699 military and veteran patients who had coccidioidomycosis before the advent of effective antifungal therapy, we identified 25 cases in which the manifestations of meningeal dissemination were described. Of 21 patients who had an identifiable initial infection, 16 developed meningeal symptoms (most frequently headache, vomiting, and nuchal rigidity) within the next 6 months. Associated pulmonary lesions were significantly more frequent in the right than in the left lung, as was also the case among 47 matched control patients who had coccidioidomycosis but not meningitis. Of 17 patients whose meningeal symptoms developed during the period studied, all died within 31 months. However, four of eight patients whose onset of symptoms preceded the study period survived for 55–146 months. Patients whose extrapulmonary dissemination involved only the meninges survived significantly longer than did those with more extensive infections. Even without therapy, the white blood cell count in cerebrospinal fluid markedly decreased during the course of the infection. The quantitative analysis provided herein offers a basis for meaningful comparisons with patients enrolled in current and future trials of therapy for coccidioidal meningitis.
UR - http://www.scopus.com/inward/record.url?scp=0027465389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027465389&partnerID=8YFLogxK
U2 - 10.1093/clind/16.2.247
DO - 10.1093/clind/16.2.247
M3 - Article
C2 - 8443303
AN - SCOPUS:0027465389
SN - 1058-4838
VL - 16
SP - 247
EP - 254
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 2
ER -